JOURNAL OF HEART AND LUNG TRANSPLANTATION

Scope & Guideline

Elevating Research in Cardiology and Respiratory Medicine

Introduction

Welcome to your portal for understanding JOURNAL OF HEART AND LUNG TRANSPLANTATION, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1053-2498
PublisherELSEVIER SCIENCE INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1991 to 2024
AbbreviationJ HEART LUNG TRANSPL / J. Heart Lung Transplant.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressSTE 800, 230 PARK AVE, NEW YORK, NY 10169

Aims and Scopes

The Journal of Heart and Lung Transplantation focuses on advancing the science and practice of organ transplantation, particularly concerning heart and lung procedures. It aims to disseminate groundbreaking research, clinical experiences, and consensus guidelines that shape the future of transplantation practices.
  1. Clinical Outcomes and Patient Management:
    The journal emphasizes studies related to clinical outcomes in heart and lung transplant recipients, focusing on patient management strategies, post-operative care, and long-term follow-up.
  2. Innovative Transplant Techniques and Technologies:
    It highlights advancements in surgical techniques, mechanical circulatory support devices, and organ preservation technologies, showcasing how these innovations improve transplantation success.
  3. Immunology and Rejection Mechanisms:
    Research related to immune responses, including antibody-mediated rejection and the role of different immunosuppressive therapies, is a core focus, exploring how these factors influence graft survival.
  4. Socioeconomic and Racial Disparities:
    The journal addresses disparities in transplantation outcomes based on socioeconomic status and race, aiming to bring attention to inequalities in access to transplant services.
  5. Emerging Therapies and Biomarkers:
    It includes studies on new therapeutic approaches, biomarker identification for predicting rejection, and monitoring graft health, contributing to personalized medicine in transplantation.
The Journal of Heart and Lung Transplantation has been at the forefront of several emerging themes that reflect the current trends in transplantation science and practice. These trends highlight the journal's commitment to addressing contemporary challenges and innovations in the field.
  1. Donor-Derived Cell-Free DNA Monitoring:
    The use of donor-derived cell-free DNA as a biomarker for graft health and rejection surveillance has gained prominence, reflecting an increasing interest in non-invasive monitoring techniques.
  2. Telehealth and Remote Monitoring:
    With the rise of digital health, studies exploring telehealth applications for monitoring transplant recipients and improving patient engagement are trending, particularly in the context of the COVID-19 pandemic.
  3. Holistic Approaches to Patient Care:
    There is a growing emphasis on the psychosocial aspects of transplantation, including caregiver support, mental health interventions, and quality of life assessments for patients.
  4. Personalized Medicine in Transplantation:
    Research focused on tailoring immunosuppressive therapies based on individual patient and donor characteristics is emerging as a crucial area, promoting better outcomes.
  5. Integration of Machine Learning and AI in Transplantation:
    The application of machine learning models to predict transplant outcomes and assess risk factors is becoming increasingly popular, facilitating data-driven decision-making in clinical practice.

Declining or Waning

As the field of organ transplantation evolves, certain themes within the Journal of Heart and Lung Transplantation have shown a decline in focus. This could reflect shifts in clinical priorities, research funding, or advancements in technology that render previously critical areas less prominent.
  1. Traditional Immunosuppression Protocols:
    There is a noticeable decrease in studies focused solely on traditional immunosuppressive regimens, as newer therapies and personalized approaches gain traction.
  2. Longitudinal Studies on Aging Donor Organs:
    Research centered on the aging of donor organs and its effects on transplantation outcomes appears to be waning, possibly overshadowed by advancements in organ preservation and procurement techniques.
  3. Basic Science Studies on Transplant Immunology:
    While fundamental research remains important, there has been a shift towards clinical applications and practical outcomes, resulting in fewer basic science studies being published.
  4. Single-Center Studies:
    As multicenter collaborations become more common, the focus on single-center studies is declining, likely due to the need for broader data to support findings.
  5. Historical Case Studies and Anecdotal Evidence:
    The journal has seen a reduction in the publication of historical case studies as the focus shifts to evidence-based practices and current clinical guidelines.

Similar Journals

JTO Clinical and Research Reports

Transforming Research into Practice for Better Patient Outcomes
Publisher: ELSEVIERISSN: Frequency: 12 issues/year

JTO Clinical and Research Reports is an esteemed open-access journal published by Elsevier, dedicated to advancing knowledge in the fields of Oncology and Pulmonary and Respiratory Medicine. Since its inception in 2020, the journal has rapidly gained recognition, achieving a commendable Q1 ranking in both fields as of 2023, highlighting its significant contribution to high-quality research and clinical practice. With an inclusive global reach, JTO Clinical and Research Reports fosters collaboration by allowing unrestricted access to its content, ensuring that vital research findings can be disseminated widely among researchers, clinicians, and students alike. Located in the United States, and with its editorial base in the Netherlands, this journal not only embraces the mission of open science but also strives to publish impactful studies that address critical challenges in cancer treatment and respiratory health. Through its rigorous peer-review process and commitment to excellence, JTO Clinical and Research Reports aims to be at the forefront of scientific discourse and innovation in these dynamic areas of medicine.

Progress in Transplantation

Advancing the Future of Organ Transplantation
Publisher: SAGE PUBLICATIONS INCISSN: 1526-9248Frequency: 4 issues/year

Progress in Transplantation is a leading journal published by SAGE Publications Inc, focusing on the dynamic field of transplantation medicine. With an ISSN of 1526-9248 and E-ISSN 2164-6708, this journal serves as a crucial platform for researchers and clinicians aiming to share cutting-edge findings and advancements in organ transplantation. Despite not being an Open Access journal, it provides a significant contribution to the academic community, evidenced by its placement in the Q3 category of Transplantation for 2023 and its ranking of #33 out of 54 in Scopus, showcasing a percentile standing of 39th. Progress in Transplantation has been dedicated to publishing high-quality research since its inception in 2000, and it continues to be a vital resource for those seeking to enrich their knowledge and foster innovation within the field of transplantation, fostering collaboration among practitioners, researchers, and students alike.

International Journal of Organ Transplantation Medicine

Empowering Global Collaboration in Transplantation Research
Publisher: AVICENNA ORGAN TRANSPLANT CENTERISSN: 2008-6490Frequency: 4 issues/year

The International Journal of Organ Transplantation Medicine, published by the Avicenna Organ Transplant Center, stands as a vital resource for the field of transplantation medicine. Established to advance scientific knowledge and clinical practices, this open access journal has been supporting the global research community since 2010, ensuring that groundbreaking findings are easily accessible to researchers, professionals, and students alike. With its ISSN of 2008-6490 and E-ISSN 2008-6482, the journal consistently showcases high-quality, peer-reviewed articles, addressing critical advancements in transplantation techniques, patient care, and immunology. Renowned for its commitment to excellence, it holds a Q3 ranking in transplantation for 2023 and ranks #32 out of 54 in the Scopus medicine transplantation category, placing it in the 41st percentile. Researchers are encouraged to submit their work, contributing to the journal's goal of improving outcomes in organ transplantation and fostering collaboration across disciplines.

Current Transplantation Reports

Innovating Tomorrow's Transplant Medicine Today
Publisher: SPRINGERNATUREISSN: Frequency: 4 issues/year

Current Transplantation Reports, published by SpringerNature, is a leading journal in the field of transplantation science, offering vital insights into the cutting-edge developments in transplant medicine and related disciplines. With an impressive array of quartile rankings, including Q2 in Nephrology and Transplantation, and Q3 in Hepatology and Immunology for 2023, this journal plays a significant role in bridging research and clinical practice. Focused on fostering innovation, the journal spans a wide spectrum of topics, from surgical advances to immunological considerations of transplant procedures. It serves as an invaluable resource for researchers, healthcare professionals, and students interested in the latest advancements and data in transplantation, recognizing the importance of disseminating knowledge in this evolving field. Although currently not designated as Open Access, it provides rigorous peer-reviewed articles that contribute to the academic community's understanding of transplantation scenarios and challenges faced in clinical settings.

Expert Review of Respiratory Medicine

Empowering Professionals with Cutting-Edge Respiratory Insights
Publisher: TAYLOR & FRANCIS LTDISSN: 1747-6348Frequency: 6 issues/year

Expert Review of Respiratory Medicine is a leading journal published by Taylor & Francis Ltd, dedicated to advancing the field of respiratory medicine through evidence-based research and comprehensive reviews. With a robust ISSN of 1747-6348 and an E-ISSN of 1747-6356, the journal disseminates essential insights into pulmonary and respiratory health, ranking an impressive #33 in Medicine - Pulmonary and Respiratory Medicine on Scopus, reflecting its significant contribution to this discipline. Established in 2007 and extending its reach through 2024, Expert Review of Respiratory Medicine serves as a crucial resource for professionals and researchers dedicated to improving respiratory health outcomes. Though not designated as an open-access journal, its impactful articles are pivotal in shaping clinical practices and guiding future research in respiratory medicine and related fields, including public health and immunology. By engaging with this journal, readers can stay abreast of the latest developments and critically evaluate advancements in respiratory care.

Experimental and Clinical Transplantation

Bridging Research and Clinical Practice in Transplantation
Publisher: BASKENT UNIVISSN: 1304-0855Frequency: 6 issues/year

Experimental and Clinical Transplantation is a distinguished journal published by Baskent University in Turkey, dedicated to advancing the field of transplantation through innovative research and clinical insights. Established in 2003, the journal has rapidly gained recognition within the academic community, currently holding a Q3 ranking in the field of Transplantation for 2023, as evidenced by its position in the Scopus ranking for the discipline. With an emphasis on both experimental and clinical studies, this journal serves as a crucial platform for sharing breakthroughs in transplant medicine, immunology, and post-operative care strategies. Although it operates under a restricted access policy, the journal seeks to bridge the gap between research findings and practical applications in clinical settings, making it invaluable for researchers, healthcare professionals, and students alike who are keen on exploring advancements in the transplantation landscape. Through its commitment to quality and innovation, Experimental and Clinical Transplantation contributes significantly to enhancing patient outcomes and fostering scholarly dialogue in the transplantation community.

HEART & LUNG

Unveiling Innovations in Cardiac and Respiratory Care
Publisher: MOSBY-ELSEVIERISSN: 0147-9563Frequency: 6 issues/year

HEART & LUNG is a premier academic journal published by MOSBY-ELSEVIER, focusing on the critical intersections of cardiology, critical care, and respiratory medicine. Since its inception in 1973, the journal has established a significant reputation within the medical community, as evidenced by its impressive Q2 ranking in key categories such as Cardiology and Cardiovascular Medicine, Critical Care and Intensive Care Medicine, and Pulmonary and Respiratory Medicine for the year 2023. With a dedicated readership comprising researchers, healthcare professionals, and students, HEART & LUNG serves as a vital platform for disseminating cutting-edge research, clinical innovations, and comprehensive reviews that influence practice standards and enhance patient care. While it currently does not offer Open Access options, readers can access a wealth of information pivotal to the advancement of medical knowledge and practice through conventional subscription. Explore the latest findings and contribute to the ever-evolving landscape of cardiovascular and respiratory health through this esteemed journal.

Transplantation Direct

Advancing the Frontiers of Transplantation Research
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2373-8731Frequency: 12 issues/year

Transplantation Direct is a leading open access journal in the field of transplantation, published by the prestigious Lippincott Williams & Wilkins. Since its inception in 2015, the journal has provided a vital platform for the dissemination of high-quality research and advancements related to organ transplantation. With an impact factor that places it in the Q2 category among transplantation journals, it ranks #22 out of 54 in the Medicine - Transplantation Scopus classification, reflecting its significance and authority within the discipline. The journal not only covers a broad scope of topics related to transplantation but also encourages global collaboration and knowledge exchange amongst researchers, clinicians, and students. With its open access model, Transplantation Direct ensures that groundbreaking findings are accessible to a wider audience, fostering innovation and enhancing patient care worldwide. For more information, visit their address at TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103.

AMERICAN JOURNAL OF TRANSPLANTATION

Pioneering research in organ transplantation and immunology.
Publisher: ELSEVIER SCIENCE INCISSN: 1600-6135Frequency: 12 issues/year

American Journal of Transplantation, published by Elsevier Science Inc, is a premier academic journal dedicated to the critical field of transplantation. With an impressive impact factor and prestigious rankings in Immunology and Allergy, Pharmacology (medical), and Transplantation, it stands as a leading source of high-quality research in these domains, boasting a Q1 category status since 2023. The journal serves an essential role in advancing scientific knowledge and clinical practices, publishing cutting-edge studies that address pressing issues in organ transplantation and immunology. Researchers, healthcare professionals, and students will find valuable insights through rigorous peer-reviewed articles that focus on innovative methodologies, outcomes, and the latest developments within transplantation science. As the journal continues to evolve from its inception in 2001 to its ongoing contributions through 2024, it remains a key resource for those looking to stay at the forefront of transplantation research and practice.

Indian Journal of Transplantation

Elevating Standards in Transplantation Care
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2212-0017Frequency: 4 issues/year

Indian Journal of Transplantation (ISSN: 2212-0017, E-ISSN: 2212-0025), published by Wolters Kluwer Medknow Publications, serves as a pivotal resource in the expanding field of transplantation medicine. As an Open Access journal since 2011, it provides unrestricted access to cutting-edge research, facilitating the dissemination of knowledge among practitioners, researchers, and students globally. With a growing focus on transplant-related advancements from 2020 to 2024, the journal has positioned itself within the Q4 category in Transplantation, underscoring its commitment to publishing valuable contributions that aim to enhance clinical practices and improve patient outcomes. Situated in the Netherlands, the journal upholds high-quality standards, inviting submissions that contribute to the understanding of various transplant procedures and practices, ultimately fostering innovation in the field. Researchers and professionals are encouraged to explore the vast array of articles, enhancing both their expertise and the community's collective knowledge in transplantation.